Cannabis
Filing of Aphria Inc.’s Form 40-F with the U.S. Securities and Exchange Commission
On August 1, 2019, Aphria Inc. (“Aphria” or the “Company”) (TSX: APHA and NYSE: APHA) filed its annual report for the fiscal year ended May 31, 2019 on Form 40-F (as amended, the “2019 Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”).
The 2019 Annual Report contains audited financial statements, management’s discussion and analysis and other disclosures. Printed copies of the Company’s fiscal 2019 annual financial statements are available free of charge to Aphria Inc. shareholders upon written request to [email protected].
The 2019 Annual Report can be accessed by visiting the SEC’s website (www.sec.gov) and Aphria’s website (https://aphriainc.com/investors/)
SOURCE Aphria Inc.
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan6 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf6 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis5 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care